Cost should not prevent patients from being treated properly. Co-Diagnostics, Inc. (Nasdaq: CODX) employs that same mindset. They believe patients worldwide should have access to affordable diagnostic solutions so they can receive the proper treatment. The unique, proprietary structure of CoPrimersTM molecules allows for cost-effective tests without sacrificing accuracy leading to quicker treatment and recovery.
Comps: Tactile Systems Technology, Inc. (Nasdaq: TCMD), Cue Health Inc. (Nasdaq: HLTH)
When looking in comparison, Co-Diagnostics showed higher earnings per share than Tactile Systems Technology despite being worth a third as much. Similarly, it also out-earned Cue Health on a per-share basis as well, but the market capitalizations are much more akin. In relation to both, they beat them outright in common metrics such as price to earnings, profit margin, return on equity, and debt to equity.